Baiying Bio

About:

Baiying Bio is a research and development outsourcing service provider.

Website: https://www.biointron.com

Top Investors: Gaorong Capital, Co-Stone Venture Capital, Joy Capital, LYFE Capital, Binfu Capital

Description:

Baiying Bio offers economic recombinant protein and antibody reagents and is a CRO vendor for life science researchers and biopharma companies. They provide services including HTP recombinant antibody and VHH production, bispecific antibody production, antibody humanization, VHH library generation, hybridoma sequencing, protein expression in mammalian cells, large-scale antibody production, and more. They delivered tens of thousands of recombinant antibodies to customers.

Total Funding Amount:

500M CNY

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Beijing, Beijing, China

Founded Date:

2012-01-01

Founders:

Number of Employees:

251-500

Last Funding Date:

2022-08-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai